Evidence map›Paper›PMID 25389230›Full record

ArticleJournal of the Royal Society of Medicine2015

Under-reporting of conflicts of interest among trialists: a cross-sectional study.

Kristine Rasmussen, Jeppe Schroll, Peter C Gøtzsche, Andreas Lundh

Abstract read
In one paragraph

Article in Journal of the Royal Society of Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Is Meat Industry Affiliation Associated With Study Conclusion in Nutrition Research? A Meta-Research Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  5. Doctors' Conflict-of-Interest; What it Looks Like and What to do About it.International journal of social determinants of health and health services · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Australian Clinical Trial Authors' Declarations of Industry Ties.Journal of general internal medicine · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristine RasmussenDepartment of Primary Care and Public Health, Imperial College London, London W6 8RP, UK The Nordic Cochrane Centre, Rigshospitalet Department 7811, 2100 Copenhagen Ø, Denmark kristine.rasmussen12@imperial.ac.uk.
Jeppe SchrollThe Nordic Cochrane Centre, Rigshospitalet Department 7811, 2100 Copenhagen Ø, Denmark.
Peter C GøtzscheThe Nordic Cochrane Centre, Rigshospitalet Department 7811, 2100 Copenhagen Ø, Denmark.
Andreas LundhThe Nordic Cochrane Centre, Rigshospitalet Department 7811, 2100 Copenhagen Ø, Denmark Department of Infectious Diseases, Hvidovre University Hospital, 2650 Hvidovre, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the prevalence of conflicts of interest (COIs) among Danish physicians who are authors of clinical drug trial reports and determine the extent of undisclosed COIs in trial publications.

designCross-sectional study.

settingThe 100 most recent drug trial reports with at least one Danish non-industry employed physician author published in a journal adhering to the International Committee of Medical Journal Editors' (ICMJE) manuscript guidelines. For each article, two observers independently extracted trial characteristics and the authors' COIs. Disclosed COIs were compared to what was registered on the Danish Health and Medicines Authority's public disclosure list.

participantsTrial authors who are Danish physicians.

main outcome measuresNumber of disclosed and undisclosed COIs.

resultsOne observer screened 928 articles and two observers assessed 120 articles for eligibility. The 100 included trials were published from February 2011 to May 2013 and included 318 Danish non-industry employed authors. Eighty-six of the 318 authors (27%) reported one or more COIs in the journal article. We found undisclosed COIs for 40 of 318 authors (13%) related to the trial sponsor or manufacturer of trial drugs. Seventy-nine of 318 authors (25%) had undisclosed COIs related to competing companies manufacturing drugs for the same indication and 136 (43%) had undisclosed COIs with any drug manufacturer.

conclusionsAlmost half of all authors had undisclosed COIs in clinical trials reported in journals adhering to the International Committee of Medical Journal Editors' manuscript guidelines. Self-declared COIs cannot be trusted, but public registries may assist editors in ensuring that more COIs are being reported.

Indexed as

Clinical Trials as TopicConflict of InterestResearch PersonnelCross-Sectional StudiesDenmarkDisclosurePrevalenceclinical trialsconflicts of interestdisclosuredrug industry

Identifiers

PMID25389230
PMCPMC4368454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.